Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jean-Bosco Nfetam Elat"'
Autor:
Joseph Fokam, Samuel Martin Sosso, Bouba Yagai, Serge Clotaire Billong, Rina Estelle Djubgang Mbadie, Rachel Kamgaing Simo, Serge Valery Edimo, Alex Durand Nka, Aline Tiga Ayissi, Junie Flore Yimga, Désiré Takou, Sylvie Moudourou, Marinette Ngo Nemb, Jean-Bosco Nfetam Elat, Maria-Mercedes Santoro, Carlo-Federico Perno, Vittorio Colizzi, Alexis Ndjolo
Publikováno v:
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-8 (2019)
Abstract Background After the launching of the « Test & Treat » strategy and the wider accessibility to viral load (VL), evaluating virological success (VS) would help in meeting the UNAIDS targets by 2020 in Cameroon. Setting and methods Cross-sec
Externí odkaz:
https://doaj.org/article/dc8ba18bc38946c299e2af8e1143e5c8
Autor:
Serge-Clotaire Billong, Joseph Fokam, Jean de Dieu Anoubissi, Cyprien Kengne Nde, Raoul Toukam Fodjo, Marinette Ngo Nemb, Yasmine Moussa, Arlette Lienou Messeh, Alexis Ndjolo, Jean-Bosco Nfetam Elat
Publikováno v:
Heliyon, Vol 6, Iss 6, Pp e04118- (2020)
Background: HIV remains a generalised epidemic in Cameroon, with regular sentinel surveillance surveys (SSS) conducted among pregnant women to monitor the epidemiological dynamics, and for strategic policy making. Our main objective was to actualise
Externí odkaz:
https://doaj.org/article/c3c7ddec72024a01b63e77b39851215b
Autor:
Serge Clotaire Billong, Joseph Fokam, Calixte Ida Penda, Salmon Amadou, David Same Kob, Edson-Joan Billong, Vittorio Colizzi, Alexis Ndjolo, Anne-Cecile Zoung-Kani Bisseck, Jean-Bosco Nfetam Elat
Publikováno v:
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-9 (2016)
Abstract Background Retention on lifelong antiretroviral therapy (ART) is essential in sustaining treatment success while preventing HIV drug resistance (HIVDR), especially in resource-limited settings (RLS). In an era of rising numbers of patients o
Externí odkaz:
https://doaj.org/article/098e692b88864fb1aa2470c7d4f7d9d9
Autor:
Serge Clotaire Billong, Carlo Federico Perno, Joseph Fokam, Junie Flore Yimga, Rina Estelle Djubgang Mbadie, Sylvie Moudourou, Alex Durand Nka, Maria-Mercedes Santoro, Vittorio Colizzi, Rachel Kamgaing Simo, Desire Takou, Aline Tiga Ayissi, Bouba Yagai, Serge Valery Edimo, Alexis Ndjolo, Samuel Martin Sosso, Jean-Bosco Nfetam Elat, Marinette Ngo Nemb
Publikováno v:
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-8 (2019)
AIDS Research and Therapy
AIDS Research and Therapy
Background After the launching of the « Test & Treat » strategy and the wider accessibility to viral load (VL), evaluating virological success (VS) would help in meeting the UNAIDS targets by 2020 in Cameroon. Setting and methods Cross-sectional st
Autor:
Nde, Cyprien Kengne, Yawa Agbotse-Gbonfoun, Anoubissi Jean De Dieu, Messeh, Arlette, Tsimene, Florine, Mvilongo, Désiré, Onana, Roger, Billong, Serge Clotaire, Bonono, Leonard, Jean-Bosco Nfetam Elat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d085cd426768313dfa8a18731cb7cd3b
Autor:
Arlette Messeh, Alexis Ndjolo, Joseph Fokam, Jean-Bosco Nfetam Elat, Jean de Dieu Anoubissi, Yasmine Moussa, Serge-Clotaire Billong, Cyprien Kengne Nde, Marinette Ngo Nemb, Raoul Fodjo
Publikováno v:
Heliyon, Vol 6, Iss 6, Pp e04118-(2020)
Heliyon
Heliyon
Background HIV remains a generalised epidemic in Cameroon, with regular sentinel surveillance surveys (SSS) conducted among pregnant women to monitor the epidemiological dynamics, and for strategic policy making. Our main objective was to actualise d
Autor:
Nelly Kamgaing, Sylvie Moudourou, Samuel Martin Sosso, Maria-Mercedes Santoro, Serge Clotaire Billong, Alexis Ndjolo, Fatim Cham, Vittorio Colizzi, Rachel Kamgaing, Emmanuel Eben Moussi, Leonella Mossiang, Georges Teto, Desire Takou, Joelle Nounouce Ngako Pamen, Anne-Cécile Zoung-Kanyi Bissek, Beatrice Dambaya, Joseph Fokam, Aubin Nanfack, Carlo Federico Perno, Mireille Mpoudi Ngole Etame, Edith Saounde Temgoua, Ezechiel Ngoufack Jagni Semengue, Jean-Bosco Nfetam Elat, Grace Angong Beloumou
Publikováno v:
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-6 (2020)
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-6 (2020)
Background Sub-Saharan African countries are transitioning to dolutegravir-based regimens, even for patients with extensive previous drug exposure, including first-generation integrase strand-transfer inhibitors (INSTI) such as raltegravir. Such expo
Autor:
Arlette Messeh, Celine Nguefeu-Nkenfou, Dorine Godelive Tseuko, David Same Kob, Gabriel Loni-Ekali, Joseph Fokam, Denis Snayeul-Wawo, Cyprien Kengne-Nde, Jean de Dieu Anoubissi, Serge-Clotaire Billong, Jean-Bosco Nfetam Elat, Leonard Bonono, Marinette Ngo-Nemb, Yasmine Moussa, Albert Zeh-Meka
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 11, p e0241999 (2020)
PLoS ONE, Vol 15, Iss 11, p e0241999 (2020)
BackgroundSyphilis and HIV can be transmitted from pregnant women to their children and they remain a public health problem in Africa. Our study aimed to determine the trends of seroprevalence of HIV/syphilis co-infection and syphilis infection overt
Autor:
Georges Nguefack-Tsague, Francisca Monebenimp, Omotayo Bolu, Edith Saounde Temgoua, Jean-Bosco Nfetam Elat, Jembia J Mosoko, Jacob Dee, Serge Clotaire Billong, Anne-Cecile Z-K. Bissek, Gabriel Loni Ekali, Alexis Ndjolo, Raoul Fodjo, Joseph Fokam, Samuel Martin Sosso, Edson-Joan Billong
Publikováno v:
BMC Infectious Diseases
Background In low-income countries (LICs), HIV sentinel surveillance surveys (HIV-SSS) are recommended in between two demographic and health surveys, due to low-cost than the latter. Using the classical unlinked anonymous testing (UAT), HIV-SSS among
Autor:
Yagai Bouba, Vittorio Colizzi, Jean-Bosco Nfetam Elat, Joseph Fokam, Sylvie Moudourou, Marinette Ngo Nemb, Rina Estelle Djubgang Mbadie, Serge Clotaire Billong, Serge Valery Edimo, Samuel Martin Sosso, Rachel Kamgaing Simo, Tiga A Fokam, Désiré Augustin Takou Komego, Junie Flore Yimga, Alex Durand Nka, Alexis Ndjolo
Publikováno v:
BMJ Global Health. 4:A32.3-A33
BackgroundGlobal efforts in meeting the 90–90–90 targets reveal that 70% of infected people know their HIV status, 77% of these are receiving antiretroviral therapy (ART) and 82% of treated patients have viral suppression. Since launching the ‘